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Abstract 
Background: Conflicting evidence exists about the relationship between psychotic symptoms and suicidality in 
mood disorders. We aimed to investigate the lifetime suicidality and its relationship with dimensions of the psychotic 
spectrum over the lifespan among subjects with bipolar I (BD I) or major depressive disorder (MDD).
Methods: 147 Consecutive out- and inpatients with BD I or MDD presenting for treatment at 11 Italian Departments 
of Psychiatry were administered the Structured Clinical Interview for DSM-IV Axis I Disorders, the Structured Clini-
cal Interview for the Psychotic Spectrum (SCI-PSY, lifetime version) and the Mood Spectrum Self-Report (MOODS-SR, 
lifetime version).
Results: Subjects with psychotic features did not differ from those without for MOODS-SR suicidality score. Control-
ling for age, gender and diagnosis (MDD/BD I), the SCI-PSY total score (p = .007) and Paranoid (p = .042), Schizoid 
(p = .007) and Interpersonal Sensitivity (p < .001) domain scores independently predicted lifetime MOODS-SR suicidal-
ity score in the overall sample.
Conclusions: Psychotic features, as evaluated upon the presence of delusions or hallucinations, are not associated 
with suicidality among subjects with BD I or MDD. However, more subtle dimensions of the psychotic spectrum, such 
as Interpersonal Sensitivity, Paranoid and Schizoid symptoms, show a significant relationship with lifetime suicidality. 
Our findings highlight the potential usefulness of a spectrum approach in the assessment of psychotic symptoms and 
suicide risk among subjects with BD I or MDD.
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Background
Suicide is one of the leading causes of preventable death, 
with more than 800,000 people dying by self-inflicted 
injuries every year [1].
In high-income countries, up to 90 % of people who die 
by suicide suffer from a mental disorder [2]. In particu-
lar, mood disorders are among the most important risk 
factors for suicidality [3–6]. The lifetime risk for suicide 
is estimated to be around 4 % in patients with any mood 
disorder [7] and 8 % in people with bipolar disorder [1, 
8, 9]. Importantly, the risk of suicidal behavior increases 
with comorbidity. Significantly higher risk of suicide 
has been in fact reported among individuals with more 
than one mental disorder, with odds of serious suicide 
attempts 89.7 times the odds of those with no psychiatric 
disorders [2, 10]. Moreover, recent data suggest that also 
subthreshold comorbidity might increase the risk of sui-
cidal ideation and attempts [11–15].
Several investigations in clinical and non-clinical sam-
ples have evaluated the relationship between psychotic 
symptoms and the risk of developing suicidal thoughts 
or behaviors. Recent epidemiological data have shown 
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subthreshold psychotic experiences to be predictive of 
suicidal thoughts and attempts in non-clinical popula-
tions [16–23]. Moreover, a number of studies have identi-
fied a correlation between positive psychotic symptoms, 
or positive psychotic symptoms-related distress, and sui-
cide in patients with schizophrenia [24–26]. As for mood 
disorders, some authors suggested that suicidal behaviors 
might be more frequent in patients with mood disorders 
with psychotic features with respect to those without 
[27], despite this has not been confirmed in all stud-
ies [28, 29]. Ran and colleagues [30] found higher levels 
of delusions in suicide attempters than in those without 
suicide attempts among 166 patients with affective disor-
ders. Park et al. [31] reported the same result among 1183 
subjects with depression. Suicidal ideation was found to 
be associated with psychotic features among 644 sub-
jects with unipolar or bipolar II major depression [32]. 
Song and colleagues [33] found auditory hallucinations 
and the age of first psychotic symptoms to be significant 
predictors of suicide attempts among 212 subjects with 
bipolar disorder. Conversely, Pawlak and colleagues [34] 
failed to find an association between psychotic symptoms 
and suicide attempts among 597 subjects with unipolar 
and bipolar affective disorders. Consistently, in a recent 
register-based, nationwide, historical prospective cohort 
study, evaluating 34,672 severely depressed subjects fol-
lowed at Danish psychiatric hospitals between 1994 and 
2010, psychotic depression was not identified as an inde-
pendent risk factor for suicide [35].
However, the extensive literature on suicide risk factors 
among subjects with mood disorders has mostly been 
focused on positive psychotic symptoms, while more 
subtle dimensions of the psychotic spectrum have not 
been hitherto carefully investigated.
Aim of the study The aim of this paper is to investigate 
lifetime suicidality in a sample of patients with bipolar I 
(BD I) or major depressive disorder (MDD), either with 
or without psychotic features, and to which dimensions 
of the psychotic spectrum that may have been present 
during the entire lifespan is associated.
Methods
The data were collected in 11 Italian Departments of Psy-
chiatry located at nine sites: Pisa, Bari, Cagliari, Firenze, 
Milano, Sassari, Siena, Torino, and Udine.
Participants
A consecutive sample of out- and inpatients presenting 
for treatment at the 11 Italian Departments of Psychiatry 
were invited to participate in the study. Eligible patients 
included new and continuing patients between 18 and 
60 years of age diagnosed with BD I or MDD. Exclusion 
criteria were severe medical illness or neurological dis-
eases with a known etiological link to mood disorders 
(e.g., malignancies, severe autoimmune conditions, 
degenerative neurological diseases, stroke) current sub-
stance use disorder and inability to participate because of 
the severity of psychiatric symptoms.
Ethics, consent and permissions
The Ethics Committee of the Azienda Ospedaliero-
Universitaria of Pisa (Italy) approved all recruitment 
and assessment procedures. Eligible subjects provided 
written informed consent, after receiving a complete 
description of the study and having an opportunity to ask 
questions. Subjects were not paid for their participation.
Measures
Participants filled the Mood Spectrum Self-Report [36] 
(MOODS-SR, lifetime version) and were administered 
the Structured Clinical Interview for DSM-IV Axis I 
Disorders (SCID-I/P) [37] and the Structured Clinical 
Interview for the Psychotic Spectrum (SCI-PSY, lifetime 
version) [38] through face-to-face interview. The assess-
ment was conducted by psychiatrists or residents in psy-
chiatry, who were trained and certified in the use of the 
study instruments at the Department of Psychiatry of the 
University of Pisa.
The Structured Clinical Interview for the Psychotic Spectrum 
(SCI‑PSY, lifetime version)
The SCI-PSY is a 164-item questionnaire assessing a 
broad range of psychopathological manifestations asso-
ciated with psychotic syndromes or schizoid/schizotypal 
personality disorders, as well as atypical and subthresh-
old psychotic symptoms, occurring during the lifetime 
of an individual [38]. The SCI-PSY items are organized 
into five domains. The Interpersonal Sensitivity domain 
describes the tendency to avoid others due to the fear 
of being misunderstood or criticized or to vague per-
ceptions of hostile attitudes of the others. The Paranoid 
domain covers the spectrum features encompassing 
mild hypervigilance, diffidence, suspiciousness, interpre-
tive attitude and paranoid self-reference. The Schizoid 
domain explores lack of emotional resonance, difficulty 
in showing feelings, being unemotional and unroman-
tic, the tendency to be isolated, which is typical of autism 
and schizoidism, and religiosity, superstition, magical 
and odd thoughts. The Misperceptions domain explores 
the presence of dissociative phenomena with partial or 
no insight, such as experiencing sudden changes in the 
environment, without being able to specify which ones; 
feeling that everything around is changing and becoming 
unfamiliar and unreal, perceiving sounds as unbearable 
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and amplified, or recognizing in the background indis-
tinguishable voices, or feeling the body or the reality as 
suddenly changed or strange. The Typical psychotic symp-
toms domain includes the psychotic symptoms listed in 
the DSM-IV such as delusions (e.g., persecution, refer-
ence, guilt, ruin, megalomanic and erotomanic), auditory 
hallucinations (e.g., noises or whispering voices or voices 
talking together) and visual and somatic hallucinations.
Mood Spectrum Self‑Report (MOODS‑SR, lifetime version)
The MOODS-SR questionnaire is focused on the pres-
ence of manic and depressive symptoms, traits and life-
styles that may characterize the ‘temperamental’ affective 
dysregulation that make up both fully syndromal and 
sub-threshold mood disturbances. The latter includes 
symptoms that are either isolated or clustered in time 
and temperamental traits that are present throughout 
an individual’s lifetime. The MOODS-SR consists of 161 
items coded as present or absent for one or more peri-
ods of at least 3–5 days in the lifetime. Items are organ-
ized into three manic–hypomanic and three depressive 
domains each exploring mood, energy and cognition, 
plus a domain that explores disturbances in rhythmic-
ity and in vegetative functions, including sleep, appetite 
and sexual function. The sum of the scores on the three 
manic–hypomanic domains constitutes the score for 
the manic–hypomanic component and that on the three 
depressive domains the depressive component.
Assessment of suicidality
Suicidality was assessed by means of six items of the 
MOODS-SR that explore whether the subject has ever 
experienced periods of 3–5 days or more when he or she 
thought that life was not worth living (N = 102); wished 
he/she would not wake up in the morning, or that he/
she would die in an accident or from something like a 
heart attack or a stroke (N = 103); wanted to die or hurt 
him/herself (N = 104); wanted to die and had a specific 
plan to hurt or kill him/herself (N = 105); actually com-
mitted a suicide attempt (N = 106); committed a suicide 
attempt that required medical attention (N =  107). For 
the purpose of this study, suicidality was scored accord-
ing to the number of positive answers given on these six 
items by each patient, retrieving a score ranging from 0 
to 6.
Statistical analyses
Chi-square and t tests were used to compare demograph-
ical and clinical variables between groups. Multivariate 
linear regressions were undertaken to examine whether 
SCI-PSY total and subscale scores predicted suicidality. 
Analyses were conducted using SPSS, version 20.0 [39].
Results
Sample characteristics
Suicidality data were missing in two (1.3  %) patients 
out of the total sample of 147 subjects; after the exclu-
sion of these 2 participants, the final sample of 145 sub-
jects comprised: 59 with BD I (35 with psychotic features 
according to DSM-IV, 24 with no psychotic features); 86 
with MDD (18 with psychotic features, 68 with no psy-
chotic features).
Subjects with BD I and MDD did not differ in age 
(38.3  ±  10.8 vs 41.9  ±  11.5; t  =  1.911; p  =  .058). The 
demographic and clinical characteristics of the study 
sample are provided in Table 1. Subjects with BD I and 
MDD did not differ in the MOODS-SR suicidality score 
(t = .752; p = .454) or for all SCI-PSY domain scores but 
in Typical Symptoms (t = −4.005; p = <.001).
Relationship between suicidality and psychotic features/
SCI‑PSY subscales
Subjects with psychotic features did not differ from 
those without for MOODS-SR suicidality score (t = .877; 
p =  .382). Linear regression was used with MOODS-SR 
suicidality score as the dependent variable. After control-
ling for the effects of age, gender and diagnosis (MDD/
BD I), a series of regression analyses were conducted. The 
total SCI-PSY score and each subscale were individu-
ally inserted in the second block to determine whether 
different dimensions of the psychotic spectrum signifi-
cantly predicted lifetime suicidality. The results showed 
that the SCI-PSY total score (β  =  .228; p  =  .007), as 
well as the Interpersonal Sensitivity (β =  .292; p <  .001), 
Paranoid (β  =  .172; p  =  .042) and Schizoid (β  =  .228; 
p  =  .007) domains scores independently predicted life-
time MOODS-SR suicidality score in the overall sam-
ple. After only significant domains were inserted in a 
multivariate regression analysis, also including the total 
depressive mood score of the MOODS-SR, the correla-
tion remained significant only for the Interpersonal Sen-
sitivity (B = .164; p = .044) subscale score (Table 2).
Discussion
To the best of our knowledge, this is the first study inves-
tigating the relationship between psychotic symptoms 
over the lifespan and lifetime suicidality among individu-
als with BD I or MDD by means of a spectrum approach. 
The majority of studies, in fact, explored the prevalence 
of suicidal thoughts or attempts comparing patients 
with the presence of psychotic symptoms such as delu-
sions and hallucinations, retrieving conflicting evidences 
[32–35].
Our results show no differences in lifetime suicidal-
ity between subjects with MDD and those with BD 
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I. Moreover, we did not find a significant correlation 
between suicidality and the presence of psychotic fea-
tures. According to DSM-IV criteria, these latter were 
assessed on the presence of delusion and/or hallucina-
tions. However, evaluating the study sample by means of 
our spectrum instrument encompassing not only typical 
positive symptoms, such as hallucinations and delusions, 
but also atypical, subthreshold and negative manifesta-
tions, our results suggest that further dimensions of the 
psychotic spectrum occurring across the lifespan may 
have a significant relationship with lifetime suicidality. 
In particular, linear regression analyses indicated lifetime 
suicidality to be significantly related to the Paranoid, the 
Schizoid and the Interpersonal Sensitivity domain score 
of the SCI-PSY. The latter domain remained significantly 
correlated to lifetime suicidality even when inserted 
in a regression model that included the other SCI-PSY 
domains correlated to suicidality and the total depressive 
lifetime score of the MOODS-SR. While the final regres-
sion model showed to account only for a moderate per-
centage of variance in suicidality (about 30 %), the results 
showed that for one unit increase in Interpersonal Sensi-
tivity, suicidality is expected to increase by .164 units.
Some previous studies reported a link between suici-
dality and interpersonal sensitivity. Interpersonal sensi-
tivity has been found to discriminate between individuals 
Table 1 Characteristics of the study sample
Italic values indicate statistically significant (<0.05)
* Column percentages
MDD (n = 86) BD I (n = 59) χ2 p
N (%*) N (%*)
Female 60 (69.8) 31 (52.5) 4.442 .038
Male 26 (30.2) 28 (47.5)
Marital status
 Not married 57 (66.3) 42 (72.4) .436 .469
 Married 29 (33.7) 16 (27.6)
Education
 Graduate/post-graduate 14 (16.3) 10 (17.2) 1.478 .687
 High school 27 (31.4) 23 (39.7)
 Secondary school 34 (39.5) 20 (34.5)
 Elementary school 11 (12.8) 5 (8.6)
Occupation
 Unoccupied 50 (58.1) 34 (59.6) 1.000 .498
 Occupied 36 (41.9) 23 (40.4)
Current acute phase 32 23 .865 .477
Treatment status
 Pre-treatment 6 (7.0) 6 (10.2) 2.884 .410
 Acute-phase treatment 36 (41.9) 19 (32.2)
 Maintenance 41 (47.7) 29 (49.2)
 Follow-up 3 (3.5) 5 (8.5)
mean ± SD mean ± SD t test p
MOODS-SR lifetime
 Total 57.2 (23.4) 73.2 (26.2) 3.868 <.001
 Depressive component 32.2 (14.1) 32.4 (14.6) .067 .946
 Manic component 13.9 (10.9) 28.7 (12.0) 7.689 <.001
Lifetime suicidality 2.4 (2.2) 2.3 (2.2) .752 .454
SCI-PSY lifetime
 Total 42.5 (21.9) 49.2 (23.3) 1.777 .078
 Interpersonal Sensitivity 4.5 (2.7) 4.1 (2.7) −.953 .342
 Paranoid 27.4 (14.7) 30.0 (15.2) 1.047 .297
 Schizoid 6.3 (3.2) 6.5 (3.6) .419 .676
 Misperceptions 1.3 (1.5) 1.8 (1.9) 1.763 .081
 Typical symptoms 3.1 (3.2) 6.8 (6.8) 4.005 <.001
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engaging in self-harm and those who do not engage in 
such behaviors among 1986 Air Force recruits [40]. Engin 
et al. [41] found interpersonal sensitivity among the risk 
factors for suicidal thoughts in a sample of 1992 first-
year university students. Consistently, Gupta et  al. [42] 
reported that interpersonal sensitivity might represent 
the mediating factor between cutaneous body image dis-
satisfaction and suicidal ideation in a non-clinical sample 
of 312 subjects. As for clinical samples, Stepp et al. [43] 
evaluated the relationship between attachment styles 
and self-injury among 406 patients with a broad range 
of mental disorders, including both Axis I and Axis II 
disorders, highlighting that this relationship is argu-
ably mediated by interpersonal sensitivity. We may argue 
that this latter may render individuals prone to feel eas-
ily hurt or rejected, and thus to avoid approaching oth-
ers, having pessimistic expectancies about the outcome 
of their interpersonal interactions; as a consequence, 
they may experience feelings of personal inadequacy and 
negative emotional states, such as depression or anxiety. 
In addition, such avoidance may worsen social isolation 
and social exclusion that have been shown, in turn, to be 
associated with increased suicidal risk [44–46].
Our data also showed a relationship between the Para-
noid domain of the SCI-PSY and lifetime suicidality. An 
increase in paranoid behaviors has been indicated as a 
signal of risk of suicide among subjects with schizophre-
nia [47]. Consistently, the paranoid schizophrenia sub-
type has been repeatedly associated with an elevated risk 
of suicide among other types of schizophrenia [48, 49]. 
As far as we know, however, the relationship between 
paranoid symptoms and suicidality has not been specifi-
cally evaluated among subjects with BD I or MDD.
Further, we found a relationship between lifetime sui-
cidality and the Schizoid domain of the SCI-PSY. This 
domain explores the lifetime occurrence of symptoms 
that are typical of autism, schizoidism and schizotypy. 
The comorbidity with cluster A personality disorders has 
been repeatedly shown to increase the risk for suicide in 
patients with different mental disorders, including mood 
disorders [50–52]. On the other hand, growing data indi-
cate that autistic traits may both represent an independ-
ent risk factor for suicide and increase the likelihood of 
engaging in more lethal suicidal behaviors in depressed 
patients [53, 54]. Such literature also appears consistent 
with recent reports indicating that subjects committing 
almost fatal suicide attempts show significantly lower 
self-disclosure, more schizoid tendencies and more feel-
ings of loneliness and communication difficulties than 
those who did not report medically serious consequences 
[55–57]. We might speculate that subjects with autism 
spectrum symptoms and those with schizoid or schizo-
typal traits share a common experience of interpersonal 
problems, lack of intimacy and social isolation [12]. Such 
symptoms are likely to lead to difficulties in accessing 
social support and to reduce the individual’s resilience to 
stressful life events [58], increasing feelings of helpless-
ness and hopelessness and, ultimately, giving rise to sui-
cidal thoughts and behaviors.
Several limitations of this study have to be acknowl-
edged while interpreting our findings. First, we grouped 
together patients from both in- and outpatient treatment 
settings, which may have biased reports of lifetime suici-
dality. Second, the lack of information about age of onset 
of mood disorder, number of episodes, current treat-
ment and the lack of assessment of Axis II comorbidity 
impaired us from analyzing the possible contribution of 
these factors to psychotic spectrum symptoms. Further, 
suicidality was assessed solely by selecting six questions 
of a 161-item instrument and grouping together very 
different aspects, from ideas that life is not worth living 
up to attempted suicide, preventing us from elucidating 
whether some dimensions of the psychotic spectrum 
specifically correlate with suicidal behaviors rather than 
with transient suicidal thoughts. Moreover, the use of a 
lifetime assessment did not allow us to establish whether 
the psychotic symptoms preceded, co-occurred or fol-
lowed suicidal ideation or attempts. Last, the exclusion of 
individuals with severe medical and neurological disor-
ders may have resulted in an underestimation of lifetime 
suicidality in patients with BD I or MDD.
Conclusions
In the context of the limitations listed above, we are 
reporting a significant association between lifetime sui-
cidality and some dimensions of the psychotic spectrum 
Table 2 Relationship between SCI-PSY subscales and MOODS-
SR suicidality score in the overall sample
The model entered age, sex and diagnosis (MDD/BD) in block 1 and SCI-PSY 
subscales, together with total depressive mood scores of the MOODS-SR in 
block 2
Italic values indicate statistically significant (<0.05)
B (SE) β 95 % CI p R2
Block 1
 Age −.007 (.016) −.038 −.039–.025 .657 .014
 Sex .431 (.377) .097 −.313–1.176 .254
 Diagnosis (MDD/BD) .322 (.375) .074 −.419–1.062 .392
Block 2
 Interpersonal sensitiv-
ity
.164 (.081) .203 .004–.324 .044 .303
 Paranoid −.023 (.016) −.157 −.054–.009 .154
 Schizoid .098 (.058) .153 −.017–.213 .095
 MOODS-SR depressive 
mood
.154 (.025) .461 .104–.205 <.001
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occurring over the lifespan among patients with BD I 
or MDD. Our findings suggest the potential usefulness 
of a spectrum approach in the assessment of suicidality 
among patients with mood disorders. On the other hand, 
they highlight the importance of a dimensional approach 
to rate severity for the core symptoms of schizophrenia 
not only among patients with schizophrenia spectrum 
and other psychotic disorders [59], but also among those 
with mood disorders. Further research is needed to cor-
roborate our results and to elucidate what implications, if 
any, the findings have on the assessment and treatment of 
patients with BD I or MDD.
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